1. UCL Home
  2. Research institutes
  3. Louvain Drug Research Institute
  4. Research groups
  5. Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR)
  6. Cellular and Molecular Pharmacology
  7. Publications

Publications

Bruxelles Woluwe

Selected publications

  1. Sautrey G, Zimmermann L, Deleu M, Delbar A, Souza Machado L, Jeannot K, Van Bambeke F, Buyck JM, Decout JL, Mingeot-Leclercq M-P.
    New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides.
    Antimicrob Agents Chemother. (2014), 58:4420-4430.
  2. Lorent J., Le Duff C.S., Quetin-Leclercq J., Mingeot-Leclercq M-P.
    Induction of highly curved structures in relation to membrane permeabilization and budding by the triterpenoid saponins, alpha- and delta-Hederin. Journal of Biological Chemistry (2013), 288: 14000-14017.
  3. Denamur S., Tyteca D., Marchand-Brynaert J., Van Bambeke F., Tulkens P.M., Courtoy P.J., Mingeot-Leclercq M-P.
    Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic.
    Free Radical Biology & Medicine (2011), 51: 1656-1665.
  4. Mingeot-Leclercq M-P. , Deleu M, Brasseur R, Dufrêne YF.
    Atomic force microscopy of supported lipid bilayers.
    Nat Protoc. (2008), 3: 1654-1659.
  5. Mingeot-Leclercq M-P. , Tulkens PM.
    Aminoglycosides: nephrotoxicity.
    Antimicrob Agents Chemother. (1999), 43:1003-1012.
  6. Chalhoub H, Pletzer D, Weingart H, Braun Y, Tunney MM, Elborn JS, Rodriguez-Villalobos H, Plésiat P, Kahl BC, Denis O, Winterhalter M, Tulkens PM, Van Bambeke F
    Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
    Scientific Reports (2017) 7:40208
  7. Siala W, Kucharíková S, Braem A, Vleugels J, Tulkens PM, Mingeot-Leclercq MP, Van Dijck P, Van Bambeke F
    The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase
    Nature Communications (2016) 7:13286.
  8. Anantharajah A, Faure E, Buyck JM, Sundin C, Lindmark T, Mecsas J, Yahr TL, Tulkens PM, Mingeot-Leclercq M-P, Guery B, Van Bambeke F
    Inhibition of the injectisome and flagellar type III secretion systems by INP1855 impairs Pseudomonas aeruginosa pathogenicity and inflammasome activation
    Journal of Infectious Diseases (2016) 214:1105-1116
  9. Buyck J.M., Tulkens P.M., Van Bambeke F.
    Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.
    Antimicrobial Agents and Chemotherapy (2013), 57: 2310-2318.
  10. Garcia L.G., Lemaire S., Kahl B., Becker K., Proctor R.A., Tulkens P.M., Van Bambeke F.
    Intracellular forms of menadione-dependent Small-Colony Variants of methicillin-resistant Staphylococcus aureus are hypersusceptible to beta-lactams in a model of THP-1 cells due to cooperation between vacuolar acidic pH and oxidant species.
    Journal of Antimicrobial Chemotherapy (2012), 67: 2873-2881.
full list